نتائج البحث - "Katarzyna Wnuk-Lipinska"

المساهمون: Immunologie intégrative des tumeurs (UMR 1186), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Sud - Paris 11 (UP11), Immunologie intégrative des tumeurs et immunothérapie des cancers (INTIM), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay

المصدر: Journal of Thoracic Oncology
Journal of Thoracic Oncology, Lippincott, Williams & Wilkins, 2020, 15, pp.973-999. ⟨10.1016/j.jtho.2020.01.015⟩
Lotsberg, M L, Wnuk-Lipinska, K, Terry, S, Tan, T Z, Lu, N, Trachsel-Moncho, L, Røsland, G V, Siraji, M I, Hellesøy, M, Rayford, A, Jacobsen, K, Ditzel, H J, Vintermyr, O K, Bivona, T G, Minna, J, Brekken, R A, Baguley, B, Micklem, D, Akslen, L A, Gausdal, G, Simonsen, A, Thiery, J P, Chouaib, S, Lorens, J B & Engelsen, A S T 2020, ' AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells ', Journal of Thoracic Oncology, vol. 15, no. 6, pp. 973-999 . https://doi.org/10.1016/j.jtho.2020.01.015
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol 15, iss 6
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

مصطلحات موضوعية: 0301 basic medicine, MAPK/ERK pathway, Lung Neoplasms, [SDV]Life Sciences [q-bio], Drug Resistance, Immunogenic Cell Death, Phenotypic plasticity, Cardiorespiratory Medicine and Haematology, NSCLC, 0302 clinical medicine, 2.1 Biological and endogenous factors, Medicine, Aetiology, Autophagic flux, Lung, ComputingMilieux_MISCELLANEOUS, Cancer, Tumor, Lung Cancer, 3. Good health, ErbB Receptors, Pharmaceutical Preparations, AXL receptor tyrosine kinase, Oncology, 5.1 Pharmaceuticals, 030220 oncology & carcinogenesis, Immunogenic cell death, Development of treatments and therapeutic interventions, Pulmonary and Respiratory Medicine, Cell signaling, Tumor immune microenvironment, Clinical Sciences, Oncology and Carcinogenesis, Article, Cell Line, 03 medical and health sciences, Immune system, Cell Line, Tumor, Genetics, Autophagy, Humans, Gene silencing, Oncology & Carcinogenesis, Protein Kinase Inhibitors, business.industry, Prevention, 030104 developmental biology, Drug Resistance, Neoplasm, Cancer cell, Cancer research, Neoplasm, business, Acquired EGFR TKI resistance

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d993ac0309a0a7368f75b952f591d704
https://hal.archives-ouvertes.fr/hal-03490939

6

AXL Is a Driver of Stemness in Normal Mammary Gland and Breast Cancer

المصدر: Engelsen, A S T, Wnuk-Lipinska, K, Bougnaud, S, Pelissier Vatter, F A, Tiron, C, Villadsen, R, Miyano, M, Lotsberg, M L, Madeleine, N, Panahandeh, P, Dhakal, S, Tan, T Z, Peters, S D M, Grøndal, S, Aziz, S M, Nord, S, Herfindal, L, Stampfer, M R, Sørlie, T, Brekken, R A, Straume, O, Halberg, N, Gausdal, G, Thiery, J P, Akslen, L A, Petersen, O W, LaBarge, M A & Lorens, J B 2020, ' AXL Is a Driver of Stemness in Normal Mammary Gland and Breast Cancer ', iScience, vol. 23, no. 11, 101649 . https://doi.org/10.1016/j.isci.2020.101649
iScience, Vol 23, Iss 11, Pp 101649-(2020)
iScience